Home/Biointaxis/Daniel Pérez
DP

Daniel Pérez

Chief Financial Officer

Biointaxis

Biointaxis Pipeline

DrugIndicationPhase
Gene therapy for Friedreich's ataxiaFriedreich's ataxiaPre-clinical